Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

InVivo Therapeutics Holdings Corp (NASDAQ:NVIV)

7.60
Delayed Data
As of 12:01pm ET
 +0.03 / +0.40%
Today’s Change
3.50
Today|||52-Week Range
11.80
+5.56%
Year-to-Date
Vonage Is Starting to Look Technically Attractive
Aug 18 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close7.57
Today’s open7.58
Day’s range7.42 - 7.71
Volume73,444
Average volume (3 months)266,348
Market cap$241.7M
Dividend yield--
Data as of 12:01pm ET, 08/24/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ENZEnzo Biochem Inc-0.05-0.79%
BSTCBiospecifics Technol...-0.34-0.88%
SNMXSenomyx Inc+0.10+2.55%
CDXSCodexis Inc+0.05+1.19%
Data as of 12:14pm ET, 08/24/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$0.00
Annual profit (last year)-$34.7M
Net profit margin--

Profile

Sector
Industrial Services
Industry
Engineering & Construction
Chairman &
Chief Executive Officer
Mark D. Perrin
Senior Vice President-
Operations
William D'Agostino
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs